Clinuvel Pharms (CLVLF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 9 31 sessions, November 3, 2025 to October 30, 2026
- Largest daily move
- -21.3% close of August 31, 2026
- 1-month change
- -12.8% closing prices, September 25, 2026 to October 30, 2026
Company Description
Clinuvel Pharms (OTC: CLVLF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $249.9M.
CLVLF has declined 12.8% over the past month. The last closing price was $4.95.
For FY2026, Clinuvel Pharms reported revenue of $64.3M with net income of $23.2M and diluted earnings per share of $0.46. The company operates at a net profit margin of 36.0%.
This page collects what Stock Titan holds for CLVLF, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
Clinuvel Pharms (CLVLF) closed at $4.95 on October 30, 2026. Over the past month, the price has lost 12.8%.
CLVLF Metrics & Rankings
Price returns through October 30, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Clinuvel Pharms has filed 10 recent SEC filings, including 9 Form 6-K, 1 Form 20-F. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CLVLF SEC filings →
Financial Highlights
Clinuvel Pharms generated $64.3M in revenue in FY2026, retaining a 82.9% gross margin, operating income reached $27.9M (43.4% operating margin), and net income was $23.2M, reflecting a 36.0% net profit margin. Diluted earnings per share stood at $0.46. The company generated $12.9M in operating cash flow. The current ratio was 14.72, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Clinuvel Pharms (CLVLF) currently stands at 2.4 million shares, up 0.1% from the previous reporting period, representing 5.6% of the float. Since November 2025, short interest has increased by 45.8%.
Days to Cover History
Days to cover for Clinuvel Pharms (CLVLF) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 195.3 to 1000.0 days.
CLVLF Company Profile & Sector Positioning
Clinuvel Pharms (CLVLF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CLVLF often look at related companies in the same sector, including Northwest Biothrputcs Inc (NWBO), Starpharma Holdings (SPHRY), Semnur Pharms Inc (SMNR), BetterLife Pharma Inc (BETRF), and Vaxart Inc (VXRT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CLVLF's relative position within its industry.